Understanding End Stage Renal Disease (ESRD) or End Stage Renal Failure? This resource provides information on ESRD diagnosis, clinical documentation requirements for End Stage Renal Failure, and associated medical coding terms for healthcare professionals. Learn about staging, treatment options, and best practices for documenting End Stage Renal Disease in medical records.
Also known as
Chronic kidney disease, stage 5
Indicates end-stage renal disease requiring dialysis or transplant.
End stage renal disease
Specifies end-stage renal disease, not otherwise specified.
Dependence on renal dialysis
Identifies patients requiring ongoing dialysis treatment.
Encounter for fitting and adjustment of extracorporeal dialysis catheter
Relates to procedures for establishing dialysis access.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the patient receiving chronic dialysis?
When to use each related code
| Description |
|---|
| Kidney failure requiring dialysis or transplant. |
| Reduced kidney function, not end-stage. |
| Sudden loss of kidney function. |
Coding ESRD requires specifying cause and comorbidities like diabetes or hypertension for accurate reimbursement and quality reporting.
Discrepancies between physician notes, lab results, and dialysis records can lead to coding errors and compliance issues.
Missing documentation of ESRD onset impacts accurate staging and can affect severity-based reimbursement and quality metrics.
Q: What are the most effective strategies for managing fluid overload in end-stage renal disease patients who are resistant to diuretics?
A: Managing fluid overload in diuretic-resistant ESRD patients requires a multifaceted approach. First, consider optimizing ultrafiltration during dialysis sessions. Explore techniques like longer or more frequent dialysis and isolated ultrafiltration. Second, evaluate and address potential contributing factors such as excessive dietary sodium intake or residual renal function. Strict dietary sodium restriction (less than 2g/day) and fluid management strategies are crucial. Consider implementing daily fluid intake and output monitoring, patient education on fluid restriction strategies, and collaborative discussions with a renal dietitian. Third, explore the potential benefits of newer agents like vaptans, but carefully weigh the risks and benefits given their potential side effects. Learn more about the latest guidelines for fluid management in ESRD patients from organizations like the National Kidney Foundation (NKF) and the Kidney Disease Outcomes Quality Initiative (KDOQI).
Q: How can clinicians differentiate between end-stage renal disease (ESRD) and acute kidney injury (AKI) in a patient presenting with rapidly declining renal function?
A: Differentiating ESRD from AKI in a patient with rapidly declining renal function necessitates a comprehensive clinical evaluation. While both present with decreased kidney function, the key lies in the timeframe and underlying etiology. AKI is characterized by a sudden decline in kidney function (hours to days), often reversible with appropriate management. Obtain a thorough medical history, focusing on potential precipitating factors for AKI such as nephrotoxic medications, infections, or recent surgeries. Conversely, ESRD develops over months to years, representing irreversible kidney damage requiring long-term dialysis or transplantation. Assess the patient's prior renal history, including any known chronic kidney disease. Laboratory tests, including serum creatinine, BUN, and urine analysis, are crucial for both diagnoses, but also consider ordering a renal ultrasound to assess kidney size and structure. Small, echogenic kidneys often suggest chronic disease, while normal-sized kidneys might point toward AKI. Explore the latest diagnostic criteria for AKI and ESRD from KDOQI guidelines to aid accurate differentiation. Consider implementing a multidisciplinary approach involving nephrology consultation for complex cases.
Patient presents with end stage renal disease (ESRD), also known as end stage renal failure, confirmed by persistently elevated serum creatinine, decreased glomerular filtration rate (GFR) less than 15 mL/min/1.73 m2, and the need for renal replacement therapy (RRT). Symptoms include fatigue, nausea, vomiting, loss of appetite, swelling in the extremities, and shortness of breath. The patient's medical history includes chronic kidney disease (CKD), hypertension, and type 2 diabetes mellitus, all of which are significant contributing factors to the development of ESRD. Diagnostic testing includes blood urea nitrogen (BUN), creatinine clearance, and urinalysis, which demonstrate the kidneys' inability to adequately filter waste products and maintain fluid balance. The patient requires dialysis or kidney transplant for survival. Treatment plan includes initiating hemodialysis three times per week, management of associated comorbidities such as anemia and mineral bone disorder, dietary restrictions to control potassium and phosphorus intake, and evaluation for kidney transplant eligibility. Patient education regarding ESRD management, dialysis access care, medication adherence, and dietary modifications has been provided. Prognosis is dependent upon adherence to treatment and the possibility of receiving a successful kidney transplant. Regular monitoring of renal function, electrolyte levels, and overall clinical status will continue. ICD-10 code N57.9 is documented for chronic kidney disease, stage 5. The patient's condition necessitates ongoing nephrology care and interdisciplinary collaboration for optimal management of this complex chronic illness.